FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2531818013> ?p ?o ?g. }

• W2531818013 endingPage "1063" @default.
• W2531818013 startingPage "1053" @default.
• W2531818013 abstract "OBJECTIVE: To evaluate whether daily enoxaparin, added to low-dose aspirin, started before 14 weeks of gestation reduces placenta-mediated complications in pregnant women with previous severe preeclampsia diagnosed before 34 weeks of gestation. METHODS: In this open-label multicenter randomized trial, we enrolled consenting pregnant women with previous severe preeclampsia diagnosed before 34 weeks of gestation, gestational age at randomization of 7–13 weeks, singleton pregnancy, and no plan for anticoagulation. Eligible patients were randomly assigned to a one-to-one ratio to receive daily either 4,000 international units enoxaparin plus 100 mg aspirin or 100 mg aspirin alone. Randomization was done by a web-based randomization system. The primary composite outcome comprised maternal death, perinatal death, preeclampsia, small for gestational age (less than the 10th percentile), and placental abruption. A sample size of 232 women equally divided into two groups was needed to detect a significant reduction in primary outcome from 55% in the aspirin group to 36.7% in the enoxaparin-aspirin group (α: 0.05, β: 0.8, two-sided). RESULTS: Between November 14, 2009, and February 21, 2015, 257 participants were enrolled. Baseline demographic and clinical factors were similar between groups. Eight women were excluded after randomization (six in the enoxaparin–aspirin group and two in the aspirin group), leaving 124 participants assigned to enoxaparin–aspirin and 125 to aspirin. Five participants were lost to follow-up (two in the enoxaparin–aspirin group and three in the aspirin group). There was no significant difference between the groups in the primary outcome: enoxaparin–aspirin 42 of 122 (34.4%) compared with aspirin alone 50 of 122 (41%) (relative risk 0.84, 95% confidence interval 0.61–1.16, P =.29). The occurrence of complications did not differ between the two groups. CONCLUSION: Antepartum prophylactic enoxaparin does not significantly reduce placenta-mediated complications in women receiving low-dose aspirin for previous severe preeclampsia diagnosed before 34 weeks of gestation. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, https://clinicaltrials.gov, NCT00986765." @default.
• W2531818013 created "2016-10-21" @default.
• W2531818013 creator A5001650037 @default.
• W2531818013 creator A5021787063 @default.
• W2531818013 creator A5025025759 @default.
• W2531818013 creator A5029642865 @default.
• W2531818013 creator A5031784288 @default.
• W2531818013 creator A5032770877 @default.
• W2531818013 creator A5039615899 @default.
• W2531818013 creator A5047276564 @default.
• W2531818013 creator A5068019922 @default.
• W2531818013 creator A5075827833 @default.
• W2531818013 creator A5076325206 @default.
• W2531818013 creator A5082513352 @default.
• W2531818013 date "2016-11-01" @default.
• W2531818013 modified "2023-10-01" @default.
• W2531818013 title "Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications" @default.
• W2531818013 cites W1569242858 @default.
• W2531818013 cites W1688650330 @default.
• W2531818013 cites W1831687225 @default.
• W2531818013 cites W1921838231 @default.
• W2531818013 cites W1954309994 @default.
• W2531818013 cites W1965194955 @default.
• W2531818013 cites W1968163772 @default.
• W2531818013 cites W1980268488 @default.
• W2531818013 cites W1985413462 @default.
• W2531818013 cites W1988820738 @default.
• W2531818013 cites W1995255121 @default.
• W2531818013 cites W1996022970 @default.
• W2531818013 cites W2002871369 @default.
• W2531818013 cites W2003953378 @default.
• W2531818013 cites W2008023699 @default.
• W2531818013 cites W2029235302 @default.
• W2531818013 cites W2058091416 @default.
• W2531818013 cites W2068714430 @default.
• W2531818013 cites W2077166963 @default.
• W2531818013 cites W2086257365 @default.
• W2531818013 cites W2094315418 @default.
• W2531818013 cites W2139870988 @default.
• W2531818013 cites W2151660358 @default.
• W2531818013 cites W2160164898 @default.
• W2531818013 cites W2332128238 @default.
• W2531818013 cites W2989714602 @default.
• W2531818013 cites W3160565403 @default.
• W2531818013 cites W4206246437 @default.
• W2531818013 cites W4232212947 @default.
• W2531818013 doi "https://doi.org/10.1097/aog.0000000000001673" @default.
• W2531818013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27741174" @default.
• W2531818013 hasPublicationYear "2016" @default.
• W2531818013 type Work @default.
• W2531818013 sameAs 2531818013 @default.
• W2531818013 citedByCount "65" @default.
• W2531818013 countsByYear W25318180132017 @default.
• W2531818013 countsByYear W25318180132018 @default.
• W2531818013 countsByYear W25318180132019 @default.
• W2531818013 countsByYear W25318180132020 @default.
• W2531818013 countsByYear W25318180132021 @default.
• W2531818013 countsByYear W25318180132022 @default.
• W2531818013 countsByYear W25318180132023 @default.
• W2531818013 crossrefType "journal-article" @default.
• W2531818013 hasAuthorship W2531818013A5001650037 @default.
• W2531818013 hasAuthorship W2531818013A5021787063 @default.
• W2531818013 hasAuthorship W2531818013A5025025759 @default.
• W2531818013 hasAuthorship W2531818013A5029642865 @default.
• W2531818013 hasAuthorship W2531818013A5031784288 @default.
• W2531818013 hasAuthorship W2531818013A5032770877 @default.
• W2531818013 hasAuthorship W2531818013A5039615899 @default.
• W2531818013 hasAuthorship W2531818013A5047276564 @default.
• W2531818013 hasAuthorship W2531818013A5068019922 @default.
• W2531818013 hasAuthorship W2531818013A5075827833 @default.
• W2531818013 hasAuthorship W2531818013A5076325206 @default.
• W2531818013 hasAuthorship W2531818013A5082513352 @default.
• W2531818013 hasConcept C126322002 @default.
• W2531818013 hasConcept C131872663 @default.
• W2531818013 hasConcept C141071460 @default.
• W2531818013 hasConcept C168563851 @default.
• W2531818013 hasConcept C204243189 @default.
• W2531818013 hasConcept C2777218350 @default.
• W2531818013 hasConcept C2777628954 @default.
• W2531818013 hasConcept C2778376644 @default.
• W2531818013 hasConcept C2779225303 @default.
• W2531818013 hasConcept C2779234561 @default.
• W2531818013 hasConcept C46973012 @default.
• W2531818013 hasConcept C54355233 @default.
• W2531818013 hasConcept C71924100 @default.
• W2531818013 hasConcept C86803240 @default.
• W2531818013 hasConceptScore W2531818013C126322002 @default.
• W2531818013 hasConceptScore W2531818013C131872663 @default.
• W2531818013 hasConceptScore W2531818013C141071460 @default.
• W2531818013 hasConceptScore W2531818013C168563851 @default.
• W2531818013 hasConceptScore W2531818013C204243189 @default.
• W2531818013 hasConceptScore W2531818013C2777218350 @default.
• W2531818013 hasConceptScore W2531818013C2777628954 @default.
• W2531818013 hasConceptScore W2531818013C2778376644 @default.
• W2531818013 hasConceptScore W2531818013C2779225303 @default.
• W2531818013 hasConceptScore W2531818013C2779234561 @default.
• W2531818013 hasConceptScore W2531818013C46973012 @default.
• W2531818013 hasConceptScore W2531818013C54355233 @default.

• next